Beijing Tongrentang Co., Ltd (SHA:600085)

Market Cap	33.70B -33.8%
Revenue (ttm)	16.64B -10.5%
Net Income	1.08B -29.6%
EPS	0.79 -29.7%
Shares Out	1.37B
PE Ratio	31.26
Forward PE	22.34
Dividend	1.00 (4.08%)
Ex-Dividend Date	n/a

Volume	5,059,126
Open	24.53
Previous Close	24.50
Day's Range	24.36 - 24.68
52-Week Range	24.25 - 38.10
Beta	0.14
Analysts	Buy
Price Target	35.82 (+45.79%)
Earnings Date	Aug 28, 2026

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills. Its products are used for cardiovascular, cerebrovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive, pediatrics, wind-dispelling and dampness removing, orthopedics, facial features, dermatological surgery, mental health, and food and beverag...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 17,284
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2025, Beijing Tongrentang's revenue was 17.26 billion, a decrease of -7.21% compared to the previous year's 18.60 billion. Earnings were 1.19 billion, a decrease of -22.07%.

Analyst Summary

According to 8 analysts, the average rating for 600085 stock is "Buy." The 12-month stock price target is ¥35.82, which is an increase of 45.79% from the latest price.

Price Target

¥35.82

(45.79% upside)

Analyst Consensus: Buy